Aspirin soon after certain bleeding stroke, after clot-busting therapy
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial studies whether starting aspirin early is safe and helpful for people who, after clot-busting treatment for an ischemic stroke, develop a specific type of small brain bleeding called hemorrhagic infarction. You might benefit if your scan later shows this pattern of bleeding and you are not able to take blood-thinners or aspirin is safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke treated with IV clot-busting medicine within 24 hours of symptom start
- Your follow-up CT scan at 24 to 36 hours after the IV treatment shows hemorrhagic infarction (a specific type of bleeding)
- You (or your legal representative) agree to join the study by signing consent
- You have NOT taken anticoagulant (blood-thinning) medicine within 1 week after the IV treatment
- You did NOT receive certain additional procedures/medicines after treatment, like tirofiban after endovascular therapy or a stent placed during surgery
- A doctor says aspirin is safe for you (no aspirin allergy or other reason you can’t take aspirin)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This trial is testing the best time to start blood thinners (anticoagulation) after emergency stroke treatment in people who have atrial fibrillation. It is for patients who had a certain type of bleeding in the brain after the procedure.
This trial tests whether starting blood thinners soon after a procedure to remove a blood clot from the brain can safely prevent another stroke in people who have atrial fibrillation. Participation is for those who had a severe stroke, received the clot-removal procedure, and are medically stable afterward.
This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.
This trial tests whether taking a low dose of aspirin soon after a stroke, when clot-busting medication has already been given, is safe and helps improve recovery. It may help prevent another stroke and is designed for people whose strokes are caused by blocked blood vessels in the brain.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
Hear when a new Antiplatelet Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.